收藏切换
Advances in pharmacokinetics and bioanalytical methods for proteolysis-targeting chimera
收藏切换
Yuxin WANG1, 2, 3, Zhiru XU1, 2, 3, *
World Clinical Drug | 2025, 46(5) : 516 - 522
Less
收藏切换
World Clinical Drug | 2025, 46(5): 516-522
• Review •
Advances in pharmacokinetics and bioanalytical methods for proteolysis-targeting chimera
Full
Yuxin WANG1, 2, 3, Zhiru XU1, 2, 3, *
Affiliations
  • 1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China
  • 2.State Key Laboratory of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry,Shanghai 200437, China
  • 3.Shanghai Professional and Technical Service Center for Biological Material Druggability Evaluation, Shanghai 200437, China
Published: 2025-05-10 doi: 10.13683/j.wph.2025.05.015
Outline
收藏切换

Proteolysis-targeting chimera (PROTAC) is a new technology for targeting protein degradation that has received great attention in the biomedical science community. PROTAC molecules can quickly and efficiently deplete target proteins by inducing degradation of target proteins using the ubiquitin-protease system, and can bind to substrates again to achieve multiple ubiquitination reactions, optimizing the dose dependence and drug resistance of traditional small molecules to a certain extent. However, this unique chemical structure and mechanism of action also brings many challenges to its in vivo and in vitro pharmacokinetic studies, mainly including poor solubility, poor permeability, poor oral absorption, and low bioavailability. Starting from the analysis of the physicochemical properties of PROTAC molecules, this article analyzed the pharmacokinetic characteristics and summarized the bioanalysis methods of such drugs. It also discussed the challenges and prospects of PROTAC technology, providing a reference for innovative research and breakthroughs in the field of PROTAC drugs.

proteolysis-targeting chimera  /  pharmacokinetics  /  bioanalytical methods
王宇昕, 徐智儒. 蛋白降解靶向嵌合体分子药代动力学及其生物分析方法的研究进展. 世界临床药物, 2025 , 46 (5) : 516 -522 . DOI: 10.13683/j.wph.2025.05.015
Yuxin WANG, Zhiru XU. Advances in pharmacokinetics and bioanalytical methods for proteolysis-targeting chimera[J]. World Clinical Drug, 2025 , 46 (5) : 516 -522 . DOI: 10.13683/j.wph.2025.05.015
Year 2025 volume 46 Issue 5
50
10
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.05.015
  • Receive Date:2024-11-21
  • Online Date:2026-11-09
  • Published:2025-05-10
Article Data
Affiliations
History
  • Received:2024-11-21
Affiliations
    1.China State Institute of Pharmaceutical Industry, Shanghai 201203, China
    2.State Key Laboratory of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry Co., Ltd., China State Institute of Pharmaceutical Industry,Shanghai 200437, China
    3.Shanghai Professional and Technical Service Center for Biological Material Druggability Evaluation, Shanghai 200437, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.05.015
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT